"As pigs were found to be affected with a form of jaundice resembling epidemic infective hepatitis in man in Denmark, the possibility of humans being infected by pork was examined. Epidemiological studies show that the number of jaundiced pigs delivered from the abattoirs have sufficed to explain the epidemics of infective hepatitis in Denmark." This quotation from Andersen's original paper reveals the basis of his experiments. He reported that the disease in pigs could be transmitted experimentally to young pigs on a quantitatively deficient diet by feeding them livers of jaundiced pigs. An increase in the icterus index of the serum and necrosis of liver cells was said to have occurred two to four days after feeding the infected livers. None of the pigs died but were killed at intervals. The same results were reported following the feeding of duodenal juice from human cases of infective hepatitis to supposedly normal pigs. Other workers have failed to confirm the results of the Danish workers. Hepatitis is rarely if ever seen in pigs in England. We have recently tried to repeat these experiments at Cambridge with the help of Mr. Venn of the Field Laboratories, Institute of Animal Pathology. Liver from fatal cases of acute yellow atrophy (either presumed infective hepatitis or following arsenotherapy) was suspended in nasal washings and duodenal juice from patients with infective hepatitis in the pre-icteric stage or on the first day of jaundice. The suspension was fed to 14 young pigs maintained on a quantitatively reduced diet. The results were entirely negative.
The Leipzig workers have reported deaths in chick embryos following inoculation on to the chorioallantoic membrane of duodenal juice collected in the pre-icteric stage of infective hepatitis and infection of canaries inoculated with filtered urine or duodenal juice collected at the same stage of the disease. The urine which is said to infect canaries produces no change in the chick embryos whilst blood which from human experiments may be presumed to be infected does not affect either chick embryo or canary. Numerous other workers have failed to confirm these results in the chick embryo and we have failed to infect 20 English canaries.
It thus appears that a universally satisfactory experimental animal has not yet been encountered.
The results of experiments in human volunteers indicate that blood from patients with infective hepatitis in the pre-icteric stage and up to two days after the appearance of jaundice is infective for man. Duodenal juice also appears to contain the infective agent in the pre-icteric stage. Neither of these findings indicates the portal of exit of the virus, but they suggest that both urine and fa£ces might contain the infective agent.
The animal experiments with material from cases of so-called homologous serum jaundice have been entirely negative.
From the experiments of Findlay and Martin in human volunteers one would deduce that there was an icterogenic agent in the nasal secretions of their cases of homologous TUNE-EXPER. MED. 1 456 Proceedings of the Royal Society of Medicile 14 serum jaundice. The agent is present in the serum in the pre-icteric stage and has been isolated from the serum of a presumed case as long as seven days after the appearance of jaundice but was absent sixty-six days after the onset of jaundice. The agent which has been found in pools of supposedly normal human serum is capable of surviving a temperature of 560 C. for an hour but is inactivated by radiation with ultraviolet light. There is suggestive evidence that the agent may be cultivated in tissue cultures of minced chick embryo. There are many debatable points in favour of and against the identity of infective hepatitis and homologous serum jaundice but there is no conclusive evidence one way or the other. It is essential to find a satisfactory susceptible experimental animal before much further knowledge can be obtained. INFECTIVE Positive -Sustained rise in level of serum bilirubin with symptoms but no clinical jaundice after same incubation period as cases that became jaundiced.
?Positive -'Sustained rise in level of serum bilirubin without symptoms, after same incubation period as cases that became jaundiced. (6) Pooled weekly specimens of a mild case in (1) 1/3 10 S.C. 0 (7) Pooled weekly specimens of a mild case in (4) 10 S.C. 0 (8) Pooled weekly specimens of a severe case in (1) 20 S.C. 3 1/3 (9) Pooled weekly specimens in a moderately severe 20 S.C. 1 case in (1) 1/3 (10) Pooled weekly specimens in the pre-icteric stage 14 S.C. 4 in 1 case in (1) (11) Single specimen of same patient as in (10) 
Homologous Serum Hepatitis
Dr. A. M. McFarlan described some of the findings in a study which the American Red Cross-Harvard Unit had made of an outbreak of hepatitis following mumps convalescent plasma. This outbreak and others had shown that occasional batches of serum or plasma gave rise to hepatitis about three months after inoculation in up to 50% of those inoculated. Although epidemiological findings and the study of groups of cases revealed some differences between infective hepatitis and homologous serum hepatitis, it was not possible to make a differential diagnosis in the individual case. It was therefore important that reports of cases of supposed homologous serum hepatitis should record the results of a search for cases of infective hepatitis in contacts and of an attempt to trace the source of the serum or plasma used. It was even more important that these investigations should be made where the transfusion of whole blood appeared to be the cause of the hepatitis, since the case against the whole blood was so far not proven.
An account of the outbreak will shortly be published. ( Post-Arsphenamine Jaundice Major James Marshall, R.A.M.C. (Command Venereologist, Eastern Command and London District): Hepatitis and jaundice occur at all stages of acquired and congenital syphilis. As a complication of treatment, jaundice was described even before the days of arsenic. Jaundice can appear at any time during the arsenical treatment of syphilis, but there are certain times at which it tends to occur most frequently. First, there is a hepatitis seen about the sixth to fifteenth day after the first arsenical injection, and often only a part of a general toxico-dermal (Milian's) reaction. Secondly, there is the delayed hepatitis, with greatest incidence about one hundred days after the start of treatment.
Both types of hepatitis can occur during or after the rapid treatment (five to thirty days) and in the long treatment of syphilis. It is possible for a patient to have an early and a delayed hepatitis with either type of treatment.
Early hepatitis.-The early hepatitis which occurs about the ninth day of treatment is commoner in intensive than in long treatment. It varies in severity from an increase in urobilinogen excretion found on routine examination to a frank icterus, but is usually mild and transient. Lloyd Jones and Maitland of the British Navy had three such early cases of jaundice in 100 intensive treatments with Mapharside of fifteen to thirty days' duration. Myers stated that the American Army in Britain had six early hepatitis cases in 750 twenty-day intensive treatments for early syphilis. All U.S. cases were accompanied by evidence of a toxico-dermal reaction of sensitization. The percentage incidence is markedly lower in the American series although the dosage of arsenoxide was generally higher than in the British Navy series of Lloyd Jones and Maitland. An important difference was that the Americans had a high carbohydrate and protein (120 g./day) diet whereas the British were on standard rations. The assumption is, however, that this type of hepatitis is a true toxic arsenical reaction.
Delayed hepatitis.-The delayed jaundice or hepatitis of the twelfth to seventeenth week after arsenical treatment starts is the commonest variety and is what is generally knoWvn as post-arsphenamine jaundice. This can occur in the treatment of any type or stage of syphilis in the adult.
Clinically post-arsphenamine jaundice is indistinguishable from infective hepatitis, biochemically no significant difference between the two has been shown so far, and pathologically Dible and McMichael have demonstrated by liver biopsy that the changes in the liver are the same in both diseases. Post-arsphenamine jaundice varies in severity from the mildest form with the faintest icterus and minimal symptoms to a fatal acute yellow atrophy. Abortive or subclinical hepatitis is quite common. £iETIOLOGY Hepato-recurrence.-Milian's theory that jaundice coincident with treatment may be a hepato-recurrence of syphilis is not really tenable. If it were true one would expect sometimes to find other evidence of relapse apart from the liver. Such evidence is not seen, however, and unless all anti-syphilis treatment is suspended for a long period during or after hepatitis' there is no evidence that the complication affects the ultimate prognosis of syphilis one way or the other. Although bismuth treatment of syphilis ought to continue through hepatitis there is good evidence, clinical and biochemical, that arsenic should be suspended until the liver has completely recovered.
Hepatitis occurring as part of a mucocutaneous relapse of syphilis is a different story and is not a contra-indication to the use of arsenicals.
Arsenic.-It is certain that arsenic itself has some part in the aetiology of the late post-arsphenamine jaundice, but it is not the prime factor and may not even be the most important. Increasing the total dose of arsenic over a given time has been shown by Curtis to increase the incidence of jaundice. lIle quotes from the records of the Whitechapel Clinic where an increase in dosage from 7-5 g. to 13 g. of an arsphenamine in a thirteen-week course caused an increase in jaundice incidence from 7 or 8% to 25 to 30%.
Marked reduction of the dose of arsenic by the use of arsenoxide instead of neoarsphenamine, the drug commonly used in Britain, has been said to reduce the incidence of jaundice. It is my own impression, and this is confirmed by some of my colleagues, that in the long treatment of syphilis when arsenoxide is used in what I consider adequate dosage, that is by twice weekly injections of the full dose, there is no significant change in incidence of jaundice. In the British Army, a reduction in dosage in the standard ten-week course of arsenical treatment from a tqtal of about 6 g. of neoarsphenamine to about 4 g. had no obvious effect in reducing the incidence of jaundice. (A minimum of four such courses is given in early syphilis.) No particular brand or batch of neoarsphenamine has ever been incriminated in any of my clinics as especially liable to produce jaundice.
Variations in incidence.-Post-arsphenamine jaundice has long been observed to parallel in rate of incidence the infective hepatitis rate in the non-syphilitic population. This was noted by Ruge in Germany and by many others. The syphilitic is, however, much more liable, possibly twenty to forty times more liable,'to jaundice than the otherwise healthy person. This is true at the present time as has been shown by Mitchell in the Canadian Army in Britain. The incidence of post-arsphenamine jaundice is inclined to rise in times of economic stress, with consequent dietary deficiency, as was pointed out by V. E. Lloyd and others.
At this time we may recall that in places such as West Africa where the staple diet is very low in protein the incidence of all types of liver disease is very high. The present increase in incidence of jaundice began in my area, Eastern England, in early 1941, reached its highest level about mid 1942, and has remained high ever since. The rate of rise was not the same in all areas. It was first observed south and southwest of London and a little later in London itself. Marked'rise in incidence was only obvious in the eastern counties late in 1942 and in-1943. The incidence varies enormously in different clinics and in different parts of the country and has varied in my area from about 20 to about 50 % in different places at the same time.
An odd circumstance is that the incidence of jaundice in civil V.D. clinics and in R.A.F. personnel in the same area is very much lower than in the military clinics although the routine of treatment, drugs, and methods of sterilization of equipment are not materially different. The incidence of jaundice in officers is at least as high as in soldiers. In peacetime the counterpart of the officer, the private patient, practically never got jaundice.
Women seldom get post-arsphenamine jaundice. The incidence in my own female clinics, civil and military, is well under 5%. The Service women under my direct care are treated exactly the same way as the men and with the same syringes.
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Sectiont of Experimental Medicine and Therapeutics 455 Sulphydryl anmino-acids. There is no doubt that diet is an important factor in the problem ot post-arsphenamine jaundice. Whipple and others have demonstrated the protective powers of sulphur-containing amino-acids against liver damage after the administration of chloroform and other liver poisons. Working under the direction of Professor John Beattie, I have carried out a number of experiments to assess the value of the sulphur-containing amino-acids as prophylactic agents against post-arsphenamine jaundice. The majority of syphilitics who get jaundice get it at or about the hundredth day or about the time of the eleventh injection of arsenic under the armv routine scheme. Prophvlactic treatment was started before the peak of incidence and was carried beyond it. Control cases were also observed, and in this group the incidence of jaundice at about the hundredth day was about 50OO. The materials used in the experiments were:
(1) Papain digest of pure casein; (2) digest with added cystine; (3) pure cystine; (4) pure methionine.
The papain digest alone was of no value. Digest plus cystine and pure cystine were effective, and methionine is also effective although this experiment is not yet complete.
The results can be summarized by saying that so far as I have gone, the incidence of hepatitis has not been reduced, but that the time of appearance of jaundice can be altered, and this is important from the point of view of the svphilis treatment as I shall explain later. In the successful experiments with digest plus cystine and pure cystine about 50k,Y! of patients showed minimal signs of hepatitis around the hundredth day, but these signs were transitorv and arsenical treatment continued to the twentieth injection, i.e. to the end of the second treatment phase. After cessation of prophylaxis and when the third treatment phase began, these same patients developed post-arsphenamine jaundice. The jaundice was treated with the protective amino-acids and it was of interest to note that those who were protected with cystine alone did not respond to cystine treatment for the jaundice, but did respond to treatment with digest plus cystine.
The explanation suggested is that the important amino-acid is methionine, which was a constituent of the digest, and that cystine may have a limited action in sparing methionine.
The work with pure methionine is not yet far enough advanced to give any final results, but it can be said that the incidence of hepatitis at the hundredth day has been reduced.
The value of these seemingly inconclusive results is this: The partial protection afforded these men enabled them to have their first twenty arsenical injections regularly and without interruption by jaundice. This would certainly enhance their chance of a rapid cure of their svphilis which is jeopardized if arsenical treatment is interrupted at about the eleventh injection as is the case when jaundice appears at the usual time.
Syrinzge infection.-Until recently syringes in my clinics and most others have been sterilized by washing in running water followed by immersion in methvlated spirits. The possibility of transmission of an infective agent by syringes used for intravenous injection of arsenic has been suggested. There are many pointers that this is the case. In order to try to prove the point some patients with syphilis at one of my hospitals wvere each given a special new syringe and needle, boiled before and after injections, and used by no other patient. Many patients were started but postings redLuced the number who continued for sufficient time to be relevant to only six cases. Not one developed jaundice at or about one hundred days after treatment started. The incidence in controls was 50%,.
One of the six is interesting. He had his first injectioin on 26.5.43. His eleventh and twelfth injections were given at a civil clinic while he was on leave on 2 and 8.9.43. They were given with a syringe used for other patients and sterilized in methylated spirits. Subsequent injections were given with his own syringe. Eighty-three davs after his first injection at the civil clinic he showed signs of liver damage and subsequently became jaundiced. Again, in mv records I have found cases coming into my clinic after treatment in other areas where jaundice incidence is low, and developing jaundice while under my care. In eight such cases jaundice developed between 190 and 405 days after the first arsenical injection. The lapse between the first injection at my clinic, where incidence is high, and the first sign of jaundice lav between 89 and 110 days. This is certainlv suggestive of an infection occurring on changing clinics. The same phenomenon has been noted at another of my hospitals.
I have also seen and heard of non-svphilitic patients who, given intravenous injections of drugs of various kinds with syringes from venereal diseases departments, have developed jaundice about a hundred davs later.
Differences between infective hepatitis anzd post-arsphenainine ijaundice. It would appear that the onlv outstanding difference between post-arsphenamine jaundice and infective hepatitis is in length of incubation period and in mode of spread.
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The incubation or latent period for post-arsphenamine jaundice is about one hundred days and spread is probably by infected syringes. In iniective hepatitis the incubation period is about thirty days, spread is probably by droplet infection, and according to Pickles an immunity is conferred comparable with that after measles. Professor Beattie and I have noted in one hospital where post-arsphenamine jaundice and infective hepatitis cases are treated in the same ward a number of instances where post-arsphenamine jaundice cases have had another attack of jaundice about thirty days after they left hospital. This, and other evidence, suggested that they had been infected with infective hepatitis, or thirty-day jaundice, while in hospital. None of the cases of infective hepatitis relapsed after leaving hospital. If our assumption is correct it would mean that an attack of post-arsphenamine jaundice confers no immunity against infective hepatitis. SUMMARY Post-arsphenamine. jaundice has an incubation period of about one hundred days and is probably due to a combinatispn of factors: (1) An infective factor introduced by syringe; (2) dietetic deficiency of protein with emphasis on sulphur-containing aminoacids; (3) arsenic.
Its control lies in: (1) Proper sterilization of syringes in venereal diseases clinics; (2) increase in diet, particularly in protein.
As far as treatment of established jaundice is concerned, I wish to say emphatically that the high carbohydrate and low fat and protein diet advocated in the past and used still by the majority of doctors is quite useless. The best results are obtained with a high protein, high cAlorie diet, chosen at the discretion of the patient, supplemented bv two pints of dried or fresh milk and an egg, dried or fresh, each day.
Hepatitis Following Yellow-Fever Vaccinations
Lt.-Colonel Theodore L. Badger, U.S.A.M.C.: The epidemic of hepatitis in the United States Army that followed the preventive inoculations with yellow-fever vaccine appeared simultaneously in whatever part of the world United States Troops were stationed in the spring and early summer of 1942. Northern Ireland was the centre of nearly all cases appearing in the United Kingdom, but what occurred there was merely a sample of the outbreaks of jaundice in other theatres. The General Hospital cared for 1,318 cases of the disease on its wards from May 21, 1942, up to December 21, although the height of the epidemic had passed by mid-August.
The clinical picture of this acute hepatitis was marked by a subacute course, where symptomatic mildness was no consistent index of the severity of liver damage. The onset was one of gastro-intestinal complaints, of nausea and vomiting, variable abdominal pain, exhausting fatigue, great loss of weight, joint pains, and finally by the sudden appearance of dark brown urine and jaundiced eyes. A marked bradycardia, low blood-pressure, striking absence of fever throughout the entire course of the disease and a normal urine except for bile pigments were characteristic features. Slow disappearance of icterus, prolonged hepatomegaly, and an enduring fatigue marked the recovery period.
The actiologv of the jaundice was obscure but severe parenchymal disease of the liver was considered the essential pathological lesion. There appeared to be an association with the yellow-fever vaccinations from the start. In conjunction with Colonel John Gordon, then director of the American Red Cross Harvard Hospital, epidemiological studies of affected units were directed toward the incidence and the origin of the disease.
Two possibilities existed in regard to the yellow-fever vaccine as the source of the epidemic. The jaundice was either an attenuated form of yellow fever, resulting from 21 Section of Experimental Medictne and Therapeutics 457 the living seed virus of the vaccine, or it arose from some factor contained in the normal human serum diluent. The preparation of the vaccine for immunization of troops was carried out by the inoculation of developing chick embryos wvith culture virus after many tissue culture passages. After incubation the virus inoculated embryo was minced and then suspended in normal human serum, filtered, adjusted to contain a standard amount of virus and then frozen and dried. From the make-up of the vaccine it appeared probable that if the seed virus were to blame a wide scattering of the jaundice among heterogeneous lot numbers wvas to be expected. If the serum diluent contained the jaundice-producing agent the disease would tend to occur in closely allied lots. A few facts emerged from the survevs designed to reveal any relationship between the vaccine and the jaundice. A total of 80 lot numbers were encountered. 67 of these showed nio associated jaundice. Only eight lots showed a significant attack rate of 3%o or more. Five lots presented an insignificant attack rate of less than 1%. Those lots affected tended to appear in groups of closely allied numbers. One lot, No. 368, sented the same attack rate in two widely separated units. Thus emphasis was directed toward the human serum diluent as containing the jaundice-producing factor but the nature of this factor was in no way revealed. The possibilitv of altered virulence of the virus remained, however, and subsequent study was directed towards the clarification of the source of the agent in the vaccine. But if the living seed virus were the cause, in its attenuated or otherwise altered form, the clinical and laboratory evidence should v-erifv it.
Clinical studv of the jaundice, however, showed little evidence for the diagnosis of yellow fever and the absence of fever and renal involvement was inconsistent with any known form of the disease. Mouse-protection studies carried out for us by Dr. MacCallum at the Wellcome Laboratories showed no increase in protective antibodies against the vellow-fever virus over a period of weeks in all individuals studied. Thus it could be clearlv stated that the jaundice was nIot yellow fever in any form, and therefore not due to the seed virus in the vaccine.
Evidence of communicabilitv of the disease from person to person by contact wvas conspicuLously absent. A control survev of the entire General Hospital personnel for evidence of jaundice was carried out in June 1942 at the start of the epidemic and again five months later at its completion. Over 1,300 cases of hepatitis were cared for by the staff and only a single case of jaundice developed. This one was unique in the accidental self-inoculation with serum from a patient seriouslv affected with jaundice at the start of his disease, which followed the use of a lot number of high attack rate. A second studv of commuLnicabilitv was that of a coast artillerv unit heavilv affected with lot No. 368 having a high attack rate. Living within this unit in close proximity twenty-four hours a day was a group of 51 men who had never been inoculated with yellow-fever vaccine. None of these 51 men developed jaundice.
An examination of immunization records for the relationship of the appearance of jaundice to the date of immunization showed that twelve to eighteen weeks was the constant incubation or latent period between inoculation wvith velloNv-fever vaccine and the development of jaundice. This was inconsistent with all other forms of infectious jaundice or vellowv fever.
ViruLs studies, xvith animal inoculation of fresh duodenal washings and blood serum of pre-icteric and severe cases, wvere all entirelv negative. But this evidence was inconclusive, and the resources wvere inadequate for exhaustive studies of virus disease.
One case only died of hepatitis, a mortality rate roughlv of one in a thousand which is in accord with the rate in other epidemic theatres. The pathology of this one case presented no features distinguishing it from severe hepatitis vith death from acute vellow atrophv, arsenical poisoning or the hepatitis following preventive v accinations for measles and mumps.
In the Virgin Islands J. \V. Oliphant studied the transmission of yellow-fever vaccine in human VoluInteers. Using specific lot numbers of yellow-fever vaccine he stuccessfullv reproduced the characteristic clinical picture of acute hepatitis bv subcutianeotus transmission of serum from person to person with the following specific observations: (1) The jaundice-producing agent was filtrable, it survived drving at 4°C. for long periods. and it survived heating at 56°C. for thirtv minutes in the drv state. (2) The agent appeared to be neutralized bv one hour exposture to ultraviolet light. (3) The agent was present in the circulating blood before jaundice appeared. (4) The agent was not present two and a half months after disappearance of jaundice. Only one thing, however, could be definitely stated on the basis of clinical anl laboratorv proof, that the disease was not vellow fever in anv form and therefore not due to reactivation of the seed virus.
The hepatitis was apparently not spread by contact from person to person and it was Ino commonly known form of epidemic hepatitis. Evidence pointed toward the human serum diluent of the vaccine as containing the factor responsible for the jaLundice bUt no 458 Proceedings of the Royal Society of Medicine 22 information was obtained as to whether the jaundice-producing factor was a virus, a chemical or physical agent or somt allergenic product. We do know that since this epidemic all yellow-fever vaccine has been prepared without the human serum diluent and that as far as reports are available, no jaundice has followed its use.
Major M. H. Salaman, R.A.M.C.: I shall give an account of one aspect only of our work at the Royal Victoria Hospital, Netley, on jaundice occurring in men receiving intravenous injections of arsenic for syphilis, namely, the influence of the technique of injection on the incidence of the disease.
It has been suggested bv Dr. F. 0. MacCallum and others that post-arsenical jaundice may be spread from patient to patient by means of syringes imperfectly sterilized between injections. Lieut.-Colonel Bigger showed that the technique employed in many V.D.
Clinics cannot be relied on to prevent the transference of an infective agent. Briefly this technique is as follows, with local variations.
At the beginning of the morning's work the syringes and needles are boiled. Before each injection some distilled water from a bottle labelled "Sterile" is poured into a gallipot, which has been boiled. The ampoule of the drug is opened, and the powder poured into the gallipot. The solution is taken up into a syringe, the needle inserted in the vein, some blood is withdrawn into the barrel, and the injection is given, leaving a small amount of solution in the syringe to prevent injection of air. The syringe and needle are rinsed through under the tap, the needle is removed for re-boiling, and the syringe is washed out in several changes of distilled water in kidney dishes, a number of syriniges being rinsed before the water is changed. If there is an adequate supply of syringes they may be rinsed out, or allowed to lie for a short time, in weak lysol or biniodide, between the rinsings in water. Then a freshly boiled needle is fitted and the next injection given. The chief danger of this method arises from the sucking back of blood into the syringe. Col. Bigger showed that staphylococci mixed with blood, sucked into a syringe, were not completely removed or killed by a process of rinsing such as the above; they were not even reduced in number to the extent to be expected from simple dilution.
Substantially this technique has been in use for years in many V.D. Clinics. Before the war there was little to suggest that it was responsible for transference of infections.
How then can it be blamed now for the enormous wartime rise in incidence of postarsenical jaundice? First, the great increase in numbers of patients, and the shortage of syringes, have made the method much more dangerous than formerly. In a busy clinic there is not time for the syringes to lie in disinfectant for a sufficient time between injections. Second, the incidence of infective hepatitis in the general population has risen, and it is probable that the number of persons in an infective condition, that is to say, those in the prodromal stage of the disease, or healthy carriers, has increased also. Consequently the chance of transference is greater. However this may be, we have taken the transference of infection by means of syringes as the working hypothesis in the following trial. A technique of intravenous injection was devised which we believed would exclude the possibility of cross-infection. All glass syringes, lubricated with liquid paraffin, with needle attached, are sterilized by dry heat (1500 to 1600 C. for one hour) in separate test tubes. Screw-cap bottles containing approximately 10 c.c. distilled water are autoclaved. Before an injection, one orderly opens the ampoule of powdered mapharside, empties it into one of the water containers and renlaces the screw cap, without touching the lips of ampoule or bottle with his fingers. The medical officer withdraws a sterile syringe from its tube and sucks up the whole of the solution, squirting in and out to complete solution, if necessary. Meanwhile another orderly has prepared the patient's arm. The drug is injected, and the syringe immediately handed to a third orderly, who rinses it out once under the tap and replaces it in its tube. The used syringes are returned to the laboratory for cleaning, lubricating, and re-sterilizing.
It was our original intention to treat alternate new cases of early syphilis with the above technique, and to treat the rest by the old technique; but this was soon found impracticable. In order to get a rneasure of the incidence in the two groups it was necessary to keep patients attending our clinic, without remission, for at least four months, owing to the long latent neriod of the disease. Everyone with experience of army venereal practice will realize the difficulty of doing this. It was soon apparent that we could only collect an adequate experimental group by including almost every new patient. In spite of strenuous efforts to keep these patients in the district only about one-third of them remained with us for four months. Patients of the experimental group mixed freely with others in the waiting room, which was often crowded, so that there was plenty of opportunity for possible droplet spread.
In order to provide adequate control for this experiment we have followed up a considerable number of patients, originally diagnosed at Netley and treated by the ordinary technique, either wholly at Netley, or partly at Netley and partly at other clinics. Intravenous mapharside and an intramuscular bismuth preparation were used throughout. Comparison between the experimental and control groups was made after one hundred and twenty days, and again after one hundred and eighty days of treatment.
We should, of course, have liked to have had a control group strictly comparable in every way to the experimental, that is to say, treated completely at our clinic over the same period. This was not possible. The absence of such a group lays our results open to two possible criticisms. It can be said, firstly, that men treated wholly at our clinic may have a different jaundice incidence from those treated elsewhere, and secondly that there may be a seasonal change of incidence. I think we can answer these criticisms from the figures I have shown (Table I ). Analysis of the control group shows that there is no significant difference in incidence among men treated with the ordinary technique between those whose treatment began between February and June 1943 and between July and November 1943, nor between those treated wholly at Netley and those treated partly at Netley and partly elsewhere. But the difference in incidence between these groups on the one hand, and the group treated by the new technique on the other, is, we believe, significant. Instructions are now in force that all syringes must be boiled between every intravenous injection at all Army Clinics. I think the evidence which I have brought forward shows how necessary this change was. Nevertheless I myself do not believe that merely boiling svringes will meet the case. There are other possibilities of transference in a busy clinic, -against which our technique was designed to guard. Syringes which have been boiled in tap water have to be rinsed in distilled water before use. The gallipot in which the drug is used stands on the bench for long periods and is used over and over again; the lip of the bottle of sterile water from which it is filled is likely to become contaminated. All these manipulations have to be carried out by attendants who are handling patients and blood-stained syringes. Clearly there is danger of transference of infection here, even if the syringes are boiled between injections. A closed method, such as the one I have described, obviates these dangers, and, once it is organized, is considerably easier and quicker in use than the old open method.
We must expect occasional cases, even if an ideal technique is followed. There will always be some of the epidemic type occurring. Moreover one cannot exclude the possibility that arsenic may activate an otherwise healthy carrier.
There is another type of post-arsenical jaundice which we have met, and which will, I think, also continue to occur whatever technique is used. It occurs early in treatment, usually between the fifth and twenty-fifth day; a sudden onset, with rigors, fever, vomiting, and sometimes a rash, is followed by jaundice. It is probably related to the syndrome known as "erythema of the ninth day" or Milian's syndrome. Arsenic given after recovery often causes another attack, unless given in very small and slowly progressive doses. An eosinophilia is common. The condition is probably due to a hypersensitivity to arsenic. We have records of five of these cases, of which one occurred in the experimental group recently. Others are recorded in the literature.
To summarize, we have shown that by means of a technique of injection designed to eliminate the possibility of transference of infection from patient to patient it is possible to reduce the incidence of post-arsenical jaundice verv greatly. The incidence of post-arsenical jaundice in men treated by the ordinary technique for 120 days was about 40%, and for 180 days about 70%. The incidence in men treated by the new technique for 120 days was 1 out of 29, and for 180 days 1 out of 12.
I wish to thank Lieut.-Colonel A. J. King and Majors D. I. Williams and C. S. Nicol for their help in this investigation. Dr . N. F. Maclagan : I want to refer very briefly to some results obtained with the serum colloidal gold reaction in jaundice which may have some bearing on the subject under discussion. While most liver function tests do not throw any light upon aetiology the newer flocculation tests appear to be in a separate class in this respect as they give strikingly different results in certain types of liver damage.
The serum colloidal gold reaction was performed by adding 2 5 ml. of gold sol to 0O05 ml. of serum under standard conditions of pH and ionic strength (Maclagan, 1944) , a positive result being indicated by partial or complete precipitation of the gold. The reaction probably depends upon the presence in the serum of an excess of gamma globulin (Gray and Barron, 1943; Kabat et al. 1943) , which is presumably liberated into the circulation by the damaged liver cells. The table shows the results in 189 cases of jaundice. 5 represents complete precipitation and is the strongest positive, while 0 represents no precipitation and is a negative or normal result. The test is mainly positive in infective hepatitis and negative in obstructive. jaundice; it usually remains negative in obstructive-jaundice even in the presence of gross liver damage as shown by other tests, thus demonstrating a qualitative difference in these two types of liver failure. The results particularly relevant to the present discussion are those in infective hepatitis-95 % of 105 cases positive-and in arsenical jaundice (i.e. jaundice occurring during antisyphilitic treatment) in which only 42% of 50 cases were positive. This difference is statisticallv highly significant, being no less than 7-5 times its standard error (53-2+7-1). A similar preponderance of negative reactions in arsenical jaundice was noted by Hanger and Gutman (1940) with the cephalin-cholesterol flocculation test, but a parallel series of cases of infective hepatitis was not available for comparison.
The general similarity of the liver lesion in these two groups has been so much stressed recently that evidence of this type must be accepted with caution, but it does appear to indicate some essential difference in liver metabolism which demands an explanation. This is not likely to be found in the degree of liver damage which is probably at least as great in the arsenical group, as shown by the liver biopsy studies of and by other tests such as galactose tolerance and hippuric acid excretion. We are therefore left with two principal alternatives: Either arsenic modifies the response of the liver to infective hepatitis, or at least half of the arsenical cases are due to some agent different from that causing infective hepatitis. This agent could be either the arsenic itself, or an unusual strain of icterogenic virus. Unfortunately it is difficult at present to obtain any evidence which would decide between these two hypotheses, but they may possibly serve as a basis for future experiments.
I am much indebted to Major.J. Marshall who has very kindly provided most of the arsenical sera used in this work. SERUM 
